Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Minocycline HCl Microspheres for Peri-Implantitis
2012-000836-24Phase 3Completed
- Sponsor
- OraPharma
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in peri-implantitis, sponsored by OraPharma. Primary endpoint: Change in average probing depth of qualifying implant sites. Started Apr 2012; status: completed.
02
Drugs
minocycline
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on 2012-000836-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000836-24.